Celldex Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
NEEDHAM, Mass.--(BUSINESS WIRE)-- Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at the Jefferies 2012 Global Healthcare Conference in New York City on Wednesday, June 6, 2012 at 8:30 a.m. ET. A live webcast of the Companys presentation will be available online on the Presentations page of the Investors section of the Celldex website at http://www.celldextherapeutics.com and will be archived for 30 days following the event.
About Celldex Therapeutics, Inc.
Celldex Therapeutics (CLDX) is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy (PTI) Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators used in optimal combinations to create novel disease-specific drug candidates. For more information, please visit http://www.celldextherapeutics.com.
Celldex Therapeutics, Inc.
Anthony S. Marucci, 781-433-0771
President and CEO
Avery W. Catlin, 781-433-0771
Chief Financial Officer
Brad Miles, 646-513-3125
Source: Celldex Therapeutics, Inc.Copyright Business Wire 2012